No headlines found.
Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
PRNewswire (Tue, 23-Apr 7:03 AM ET)
Veeva Launches AI Partner Program
PRNewswire (Thu, 18-Apr 7:03 AM ET)
Veeva Announces Vault CRM Campaign Manager
PRNewswire (Wed, 17-Apr 7:03 AM ET)
Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement
PRNewswire (Wed, 17-Apr 7:03 AM ET)
Veeva Vault CRM Now Available for All New Customers
PRNewswire (Mon, 1-Apr 9:03 AM ET)
Veeva Vault EDC Surpasses 1,000 Study Start Milestone
PRNewswire (Wed, 20-Mar 7:03 AM ET)
Veeva to Present at Upcoming Investor Conference
PRNewswire (Mon, 4-Mar 4:05 PM ET)
Veeva Announces Fourth Quarter and Fiscal Year 2024 Results
PRNewswire (Thu, 29-Feb 4:05 PM ET)
PRNewswire (Wed, 14-Feb 7:03 AM ET)
New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding
PRNewswire (Mon, 12-Feb 7:03 AM ET)
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Systems Class A trades on the NYSE stock market under the symbol VEEV.
As of April 23, 2024, VEEV stock price climbed to $201.59 with 247,506 million shares trading.
VEEV has a beta of 1.54, meaning it tends to be more sensitive to market movements. VEEV has a correlation of 0.23 to the broad based SPY ETF.
VEEV has a market cap of $32.52 billion. This is considered a Large Cap stock.
Last quarter Veeva Systems Class A reported $631 million in Revenue and $1.38 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.08.
In the last 3 years, VEEV stock traded as high as $343.96 and as low as $151.02.
The top ETF exchange traded funds that VEEV belongs to (by Net Assets): VTI, VO, VXF, MOAT, VUG.
VEEV has underperformed the market in the last year with a price return of +8.7% while the SPY ETF gained +24.0%. VEEV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.7% and -6.2%, respectively, while the SPY returned +4.7% and -2.8%, respectively.
VEEV support price is $195.94 and resistance is $202.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VEEV stock will trade within this expected range on the day.